AlphaMissense precomputed scores (Lu et al. 2025)
AlphaMissense precomputed missense scores; stop-gains scored by the most deleterious single-nucleotide-reachable missense score downstream.
Overview
An explanatory profile has not yet been reviewed for this record.
Consult the linked sources for architecture or protocol details. Missing evidence is not evidence of a missing capability.
Evaluations and results
4 evaluations · 4 results. Different protocols are not a single leaderboard.
Protocol: ClinVar pathogenic versus benign SNVs within variant type, AUROC (Lu et al. 2025)
Sorted by AUROC (ClinVar pathogenic vs benign SNVs, Missense & 3'UTR) (higher is better). The best value in each column is highlighted. Decimals are rounded for display; each value links to the printed value and its source.
| Tested configuration | Protocol and dataset | AUROC (ClinVar pathogenic vs benign SNVs, Missense & 3'UTR) | AUROC (ClinVar pathogenic vs benign SNVs, Missense & Intron (Non-splice)) | AUROC (ClinVar pathogenic vs benign SNVs, Missense) | AUROC (ClinVar pathogenic vs benign SNVs, Stop gain) |
|---|---|---|---|---|---|
| AlphaMissense precomputed scores (Lu et al. 2025)Evaluation | Lu et al. 2025 ClinVar benchmark: Missense & 3'UTR (Figure 1) | 0.952 | Not reported | Not reported | Not reported |
| AlphaMissense precomputed scores (Lu et al. 2025)Evaluation | Lu et al. 2025 ClinVar benchmark: Missense (Figure 1) | Not reported | Not reported | 0.959 | Not reported |
| AlphaMissense precomputed scores (Lu et al. 2025)Evaluation | Lu et al. 2025 ClinVar benchmark: Missense & Intron (Non-splice) (Figure 1) | Not reported | 0.924 | Not reported | Not reported |
| AlphaMissense precomputed scores (Lu et al. 2025)Evaluation | Lu et al. 2025 ClinVar benchmark: Stop gain (Figure 1) | Not reported | Not reported | Not reported | 0.849 |
All 4 result rows with coverage, uncertainty and sources
Filter evaluations
Applied filters: All linked evaluations
Source checking is not independent reproduction. Release 2026-11-02-a7f03c9e55a5.
Use this configuration
How it works, versions and access
Additional methodological details, versions and access terms have not yet been extracted into a structured profile for this configuration. Consult the linked sources and evaluation records below.
Evidence
Source checking verifies the cited claim or transcription. It does not establish independent reproduction.
Evidence table
Inspect claims, sources and review details
Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.
One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.
0 evidence rows matching the loaded filters
| Property and statement | Original source and location | Review and provenance |
|---|
No evidence rows match these filters. Choose another scope or clear the search.
Sources and history
Release 2026-11-02-a7f03c9e55a5 · Record review: source checked
1 source record and release history
- Genomic heterogeneity inflates the performance of variant pathogenicity predictions (Lu, Liu, Lin and Brandes, bioRxiv 2025, v2) · Original source · bioRxiv preprint version 2, posted 2025-09-10 (version 1 posted 2025-09-08); full-text PDF (21 pages)
Technical metadata and extraction receipts
Stable ID: lu-hetero-20261019-config-alphamissense-precomputed
- areas
- dna-genomes
- contexts
- clinical_research
- method types
- supervised_machine_learning
- reported name
- AlphaMissense
- parameters
- Precomputed scores from alphamissense.hegelab.org; 87 variants with more than one score excluded from missense analyses; stop-gain via RefSeq to UniProt mapping (MyGene) and maximum downstream score.
- source locator
- Methods 'AlphaMissense' (page 15)
Related records
- configuration of: AlphaMissense
- system: AlphaMissense on ClinVar Missense SNVs (Lu et al. 2025 Figure 1)
- system: AlphaMissense on ClinVar Missense & Intron (Non-splice) SNVs (Lu et al. 2025 Figure 1)
- system: AlphaMissense on ClinVar Missense & 3'UTR SNVs (Lu et al. 2025 Figure 1)
- system: AlphaMissense on ClinVar Stop gain SNVs (Lu et al. 2025 Figure 1)